Publikationen von Maike Siobal

Schöttle, J.; Chatterjee, S.; Volz, C.; Siobal, M.; Florin, A.; Rokitta, D.; Hinze, Y.; Dietlein, F.; Plenker, D.; König, K. et al.; Albus, K.; Heuckmann, J. M.; Rauh, D.; Franz, T.; Neumaier, B.; Fuhr, U.; Heukamp, L. C.; Ullrich, R. T.: Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget 6 (36), S. 38458 - 38468 (2015)

Chatterjee, S.; Wieczorek, C.; Schöttle, J.; Siobal, M.; Hinze, Y.; Franz, T.; Florin, A.; Adamczak, J. M.; Heukamp, L. C.; Neumaier, B. et al.; Ullrich, R. T.: Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. Cancer Research 74 (10), S. 2816 - 2824 (2014)

Chatterjee, S.; Heukamp, L. C.; Siobal, M.; Schöttle, J.; Wieczorek, C.; Peifer, M.; Frasca, D.; Koker, M.; König, K.; Meder, L. et al.; Rauh, D.; Buettner, R.; Wolf, J.; Brekken, R. A.; Neumaier, B.; Christofori, G.; Thomas, R. K.; Ullrich, R. T.: Tumor vegf:vegfr2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation 123 (4), S. 1732 - 1740 (2013)

Ullrich, R. T.; Jikeli, J. F.; Diedenhofen, M.; Böhm-Sturm, P.; Unruh, M.; Vollmar, S.; Hoehn, M.: In-vivo visualization of tumor microvessel density and response to anti-angiogenic treatment by high resolution MRI in mice. PLoS ONE 6 (5), S. e19592 - e19592 (2011)